EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

MCF classifier: Estimating, standardizing, and stratifying medicine carbon footprints, at scale

Haroon Taylor iD, Shazia Mahamdallie, Matthew Sawyer iD, Nazneen Rahman iD

British Journal of Clinical Pharmacology · 2024

DOI: 10.1111/bcp.16229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Haroon Taylor und 3 weiteren Autor:innen. Beteiligte Einrichtung: YewMaker, London, UK. Hauptthemen laut MEDLINE: Carbon Footprint. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: SBRI Healthcare programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Healthcare accounts for 5% of global greenhouse gas emissions, with medicines making a sizeable contribution. Product‐level medicine emission data is limited, hindering mitigation efforts. To address this, we created Medicine Carbon Footprint (MCF) Classifier, to estimate, standardize, stratify and visualize medicine carbon footprints.

Methods

We used molecular weight and chemical structure to estimate the process mass intensity and global warming potential of the active pharmaceutical ingredient in small molecule medicines. This allowed us to estimate medicine carbon footprints per dose, which we categorized into MCF Ratings, accessible via a searchable web application, MCF Formulary. We performed comparison and sensitivity analyses to validate the ratings, and stratification analyses by therapeutic indication to identify priority areas for emission reduction interventions.

Results

We generated standardized medicine carbon footprints for 2214 products, with 38% rated LOW, 35% MEDIUM, 25% HIGH and 2% VERY HIGH. These products represented 2.2 billion NHS England prescribed doses in January 2023, with a total footprint of 140 000 tonnes CO 2 e, equivalent to the monthly emissions of 940 000 cars. Notably, three antibiotics—amoxicillin, flucloxacillin and penicillin V—contributed 15% of emissions. We estimate that implementing the recommended 20% antibiotic prescription reduction could save 4200 tonnes CO 2 e per month, equivalent to removing 29 000 cars.

Conclusions

Standardized medicine carbon footprints have utility in assessing and addressing the carbon emissions of medicines, and the potential to inform and catalyse changes needed to align better healthcare and net zero commitments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbon FootprintHumansPharmaceutical PreparationsEnglandGlobal Warming

Stichwörter der Autor:innen

antibioticsmedicine carbon footprintnet‐zero healthcareprescribingquality use of medicinessustainable medicines

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • YewMaker, London, UK.
  • SEE Sustainability, Leeming Bar, North Yorkshire, UK.

ORCID-Profile: Haroon Taylor, Matthew Sawyer, Nazneen Rahman

Förderung

  • SBRI Healthcare programme

Zitieren

APA

Taylor, H., Mahamdallie, S., Sawyer, M., & Rahman, N. (2024). MCF classifier: Estimating, standardizing, and stratifying medicine carbon footprints, at scale. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16229

Vancouver

Taylor H, Mahamdallie S, Sawyer M, Rahman N. MCF classifier: Estimating, standardizing, and stratifying medicine carbon footprints, at scale. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16229

BibTeX
@article{Taylor2024,
  author = {Taylor, Haroon and Mahamdallie, Shazia and Sawyer, Matthew and Rahman, Nazneen},
  title = {MCF classifier: Estimating, standardizing, and stratifying medicine carbon footprints, at scale},
  journal = {British Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1111/bcp.16229}
}
Kostenlos starten →